Friday 16 October 2026 Export CUE’s income statement to Excel — free account

Cue Biopharma, Inc.

Cue Biopharma, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $27.5 million, up 195.7% from fiscal 2024. In the quarter to June 2026, revenue grew 166.7%, EPS fell 793.2% and free cash flow fell 742.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

16.71 1.96 −10.50%

Follow CUE

Alert me

Market cap: $135.6M
P/E: 0.0×
Fwd P/E: −4.4×
Dividend yield: —
F-score: 5/9
Altman Z: −11.88
Beneish M: −0.40
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(195.19%)	(121.11%)	(138.52%)	(1,603.48%)
Piotroski F-Score Full definition →		3	5	4	3
ROA Full definition →		(98.58%)	(71.51%)	(73.49%)	(459.60%)
ROIC Full definition →		0.00%	0.00%	(294.07%)	0.00%
Return on Tangible Assets Full definition →		(355.43%)	(112.10%)	(101.21%)	(2,899.43%)
Average Days of Receivables Full definition →		19.90	73.70	59.67	52.12
Free Cash Flow per Share Full definition →		(8.87)	(6.92)	(5.11)	(7.91)
Free Cash Flow Full definition →		(29.80)	(21.82)	(24.56)	(50.13)
Capital Expenditures Full definition →		(0.16)	(0.14)	(0.11)	(0.08)
Other line items
Cash ROIC Full definition →		(84.38%)	(39.93%)	(62.91%)	(254.14%)
Accounts Receivable Turnover Full definition →		6.36	6.32	10.40	12.74
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		399.94%	137.42%	110.27%	205.00%
Selling, General and Administrative Expense of Revenue Full definition →		236.79%	59.14%	49.56%	156.98%
Share Based Compensation of Revenue Full definition →		80.23%	17.27%	10.55%	69.13%
Interest Coverage Full definition →		(95.41)	(74.38)	(84.15)	(511.22)
Operating CF/Net income Full definition →		0.79	0.82	1.25	0.31
Depreciation/Fixed assets Full definition →		0.76	3.25	4.19	4.58
Capex/Depreciation Full definition →		(0.68)	(0.17)	(0.09)	(0.07)
Revenue per Share Full definition →		2.11	8.71	6.81	5.94
Operating CF per Share Full definition →		(8.82)	(6.87)	(5.09)	(7.89)
Capex per Share Full definition →		(0.05)	(0.04)	(0.02)	(0.01)
Capex to Sales Full definition →		0.02	0.01	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly